Search research articles
Contact Us
Filters
Showing results (151-160 of 451) with videos related to
Page
of 46
Sort By:
Clinical and Molecular Hepatology
|
March 18, 2026
SEVERE HEPATITIS B FLARE AND LIVER FAILURE - CURRENT ASSESSMENT AND MANAGEMENT
Seng Gee Lim, Maria Buti, Jordan J Feld, et al.
Journal of Hepatology
|
October 26, 2019
Pitfalls in measuring temporal trends for late diagnosis of viral hepatitis
Lauren Lapointe-Shaw, Peter C Austin, Hannah Chung, et al.
CMAJ Open
|
April 13, 2017
Drug therapies for chronic hepatitis C infection: a cost-effectiveness analysis
William W L Wong, Karen M Lee, Sumeet Singh, et al.
Hepatology (Baltimore, Md.)
|
June 15, 2005
Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome
Jordan J Feld, Huong Dinh, Tamara Arenovich, et al.
Plos One
|
January 24, 2018
Population-based estimate of hepatitis C virus prevalence in Ontario, Canada
Shelly Bolotin, Jordan J Feld, Gary Garber, et al.
Plos One
|
April 16, 2015
Poor recognition of risk factors for hepatitis B by physicians prescribing immunosuppressive therapy: a call for universal rather than risk-based screening
Alissa Visram, Kelvin K W Chan, Phyllis McGee, et al.
Virus Research
|
March 20, 2025
Combination therapy enhances the antiviral activity of IFN-λ against SARS-CoV-2 and MERS-CoV
Vahid Rajabali Zadeh, Jocelyne M Lew, M Atif Zahoor, et al.
Lancet Regional Health. Americas
|
June 30, 2023
Rapid hepatitis C virus point-of-care RNA testing and treatment at an integrated supervised consumption service in Toronto, Canada: a prospective, observational cohort study
Bernadette Lettner, Kate Mason, Zoë R Greenwald, et al.
Clinical and Experimental Rheumatology
|
October 3, 2009
Intravenous colchicine treatment for six months: adjunctive therapy in familial Mediterranean fever (FMF) unresponsive to oral colchicine
M Rozenbaum, N Boulman, J Feld, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 30, 2018
Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin
Jordan J Feld, David E Bernstein, Ziad Younes, et al.
Page
of 46
Search research articles
Search
Showing results (151-160 of 451) with videos related to
Sort By:
Page
of 46
Clinical and Molecular Hepatology
|
March 18, 2026
SEVERE HEPATITIS B FLARE AND LIVER FAILURE - CURRENT ASSESSMENT AND MANAGEMENT
Seng Gee Lim, Maria Buti, Jordan J Feld, et al.
Journal of Hepatology
|
October 26, 2019
Pitfalls in measuring temporal trends for late diagnosis of viral hepatitis
Lauren Lapointe-Shaw, Peter C Austin, Hannah Chung, et al.
CMAJ Open
|
April 13, 2017
Drug therapies for chronic hepatitis C infection: a cost-effectiveness analysis
William W L Wong, Karen M Lee, Sumeet Singh, et al.
Hepatology (Baltimore, Md.)
|
June 15, 2005
Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome
Jordan J Feld, Huong Dinh, Tamara Arenovich, et al.
Plos One
|
January 24, 2018
Population-based estimate of hepatitis C virus prevalence in Ontario, Canada
Shelly Bolotin, Jordan J Feld, Gary Garber, et al.
Plos One
|
April 16, 2015
Poor recognition of risk factors for hepatitis B by physicians prescribing immunosuppressive therapy: a call for universal rather than risk-based screening
Alissa Visram, Kelvin K W Chan, Phyllis McGee, et al.
Virus Research
|
March 20, 2025
Combination therapy enhances the antiviral activity of IFN-λ against SARS-CoV-2 and MERS-CoV
Vahid Rajabali Zadeh, Jocelyne M Lew, M Atif Zahoor, et al.
Lancet Regional Health. Americas
|
June 30, 2023
Rapid hepatitis C virus point-of-care RNA testing and treatment at an integrated supervised consumption service in Toronto, Canada: a prospective, observational cohort study
Bernadette Lettner, Kate Mason, Zoë R Greenwald, et al.
Clinical and Experimental Rheumatology
|
October 3, 2009
Intravenous colchicine treatment for six months: adjunctive therapy in familial Mediterranean fever (FMF) unresponsive to oral colchicine
M Rozenbaum, N Boulman, J Feld, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 30, 2018
Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin
Jordan J Feld, David E Bernstein, Ziad Younes, et al.
Page
of 46